266 related articles for article (PubMed ID: 19814633)
1. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO
Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633
[TBL] [Abstract][Full Text] [Related]
2. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of the patients with hemodialysis associated with intracerebral hematoma].
Ikeda K; Tsuchimochi H; Takeno Y; Yasuda M; Fukushima T; Toyoda K
No Shinkei Geka; 2004 Nov; 32(11):1133-7. PubMed ID: 15570877
[TBL] [Abstract][Full Text] [Related]
4. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis.
Watanabe A
J Stroke Cerebrovasc Dis; 2007; 16(1):30-3. PubMed ID: 17689389
[TBL] [Abstract][Full Text] [Related]
5. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis.
Kawamura M; Fijimoto S; Hisanaga S; Yamamoto Y; Eto T
Am J Kidney Dis; 1998 Jun; 31(6):991-6. PubMed ID: 9631844
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting outcome of intracerebral hemorrhage in patients undergoing chronic hemodialysis.
Ochiai H; Uezono S; Kawano H; Ikeda N; Kodama K; Akiyama H
Ren Fail; 2010; 32(8):923-7. PubMed ID: 20722558
[TBL] [Abstract][Full Text] [Related]
7. Comparative outcomes between hemo- and peritoneal dialysis patients with acute intracerebral hemorrhage.
Hsieh CY; Chen CH; Wu AB; Tseng CC
Am J Nephrol; 2010; 32(1):31-7. PubMed ID: 20484897
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
11. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center.
Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC
J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522
[TBL] [Abstract][Full Text] [Related]
12. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
13. [Management of intraoperative anticoagulantless CHD with EVAL-dialyzer in four patients on maintenance hemodialysis].
Wake M; Sanagawa Y; Tanaka Y
Masui; 2002 Mar; 51(3):250-4. PubMed ID: 11925887
[TBL] [Abstract][Full Text] [Related]
14. The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.
Baek NN; Jang HR; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
Ren Fail; 2012; 34(3):279-85. PubMed ID: 22251267
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
16. The effect of systemic anticoagulation in patients undergoing angioaccess surgery.
D'Ayala M; Smith RM; Martone C; Briggs W; Deitch JS; Wise L
Ann Vasc Surg; 2008 Jan; 22(1):11-5. PubMed ID: 18055171
[TBL] [Abstract][Full Text] [Related]
17. Gross-total hematoma removal of hypertensive basal ganglia hemorrhages: a long-term follow-up.
Zuo Y; Cheng G; Gao DK; Zhang X; Zhen HN; Zhang W; Xiao SC
J Neurol Sci; 2009 Dec; 287(1-2):100-4. PubMed ID: 19801153
[TBL] [Abstract][Full Text] [Related]
18. AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis.
Ueda H; Shibahara N; Takagi S; Inoue T; Katsuoka Y
Ren Fail; 2008; 30(9):856-60. PubMed ID: 18925523
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage.
Lim JK; Hwang HS; Cho BM; Lee HK; Ahn SK; Oh SM; Choi SK
Surg Neurol; 2008 Jan; 69(1):40-5; discussion 45. PubMed ID: 18054613
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
